Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation: A Prospective, Observational, and Pilot Study

NCT06868823 is registered in ClinicalTrials.gov with University Hospital, Motol as lead sponsor.

NCT NCT06868823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06868823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation: A Prospective, Observational, and Pilot Study
Lead sponsor
University Hospital, Motol
Phase
Observational
Overall status
Recruiting
Start date
May 1, 2025
Completion date
December 31, 2025
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants and bleeding disorders, extracorporeal membrane oxygenation (ecmo), lung transplantation